Filtered by:
38 Programs
-
Practical PerspectivesPreventing and Managing Toxicities Associated with Antibody-Drug Conjugates in the Management of Metastatic Breast Cancer
-
-
L
-
R
-
L
-
-
Cancer Conference Update2025 ESMO Annual Meeting — Breast Cancer Highlights
-
-
P
-
P
-
P
-
-
P
-
P
+2 more modules
-
-
Exploring Current Patterns of Care in the Community
Optimizing the Use of Oral Selective Estrogen Receptor Degraders for HR-Positive Metastatic Breast Cancer, Part 2
-
-
J
-
R
-
J
-
-
Oncology Today with Dr Neil Love
Optimizing the Integration of ADCs into the Treatment of HR-Positive and Triple-Negative Metastatic Breast Cancer
-
-
L
-
L
-
-
L
-
L
-